Esperion Therapeutics
ESPR
#6620
Rank
C$0.90 B
Marketcap
C$3.51
Share price
2.00%
Change (1 day)
55.25%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of March 2026 (TTM): 2.12

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.43. At the end of 2025 the company had a P/S ratio of 1.76.

P/S ratio history for Esperion Therapeutics from 2013 to 2025

PS ratio at the end of each year

Year P/S ratio Change
20251.7630.1%
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.47 16.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
5.48 159.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
3.14 48.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
9.33 340.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.54 255.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
3.45 62.71%๐Ÿ‡บ๐Ÿ‡ธ USA